Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

SHA:688488 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	341.02	335.34	225.36	134.91	442.71	244.68
Trading Asset Securities	80.18	106.18	215.75	351.64	163.31	536.31
Cash & Short-Term Investments	421.2	441.52	441.1	486.54	606.02	781
Cash Growth	-10.83%	0.10%	-9.34%	-19.71%	-22.41%	502.18%
Accounts Receivable	203.86	162.92	207.62	134.74	89.68	127.02
Other Receivables	8.34	0.03	0.01	-	-	-
Receivables	212.21	162.96	207.64	134.74	89.68	127.02
Inventory	245.85	254.97	184.88	156.15	114.27	88.06
Prepaid Expenses	-	-	-	-	-	0
Other Current Assets	16.53	35.48	38.76	25.02	16.97	10.65
Total Current Assets	895.79	894.93	872.38	802.46	826.93	1,007
Property, Plant & Equipment	412.37	434.45	443.54	447.18	327.3	255.95
Long-Term Investments	78.18	69.6	150.88	148.81	58.2	1.94
Goodwill	171.62	171.62	13.24	13.24	13.24	13.24
Other Intangible Assets	159.88	175.47	114.59	117.62	128.23	54.36
Long-Term Deferred Tax Assets	86.97	83.85	54.29	39.02	19.32	7.88
Long-Term Deferred Charges	37.28	36.41	83.9	69.13	42.94	98.88
Other Long-Term Assets	2.85	3.24	13.74	18.09	18.45	7.84
Total Assets	1,845	1,870	1,747	1,656	1,435	1,447
Accounts Payable	102.79	37.5	35.67	27.34	28.1	29.93
Accrued Expenses	16.86	82.1	39.2	35.11	20.11	20.74
Short-Term Debt	289	220.5	255.55	145.16	-	-
Current Portion of Long-Term Debt	119.74	169.05	80.07	0.07	-	-
Current Portion of Leases	-	4.22	3.78	2.05	4.23	-
Current Income Taxes Payable	14.04	0.82	-	-	-	3.13
Current Unearned Revenue	5.73	13.08	6.25	33.12	2.43	8.37
Other Current Liabilities	83.76	121.79	71.04	88.83	37.67	10.84
Total Current Liabilities	631.92	649.06	491.57	331.68	92.54	73
Long-Term Debt	71.74	90.51	69.94	60	-	-
Long-Term Leases	4.07	3.75	2.96	1.5	1.36	-
Long-Term Unearned Revenue	45.54	49.74	50.29	56.37	25.05	7.25
Long-Term Deferred Tax Liabilities	9.7	9.43	6.28	7.02	5.86	6.72
Total Liabilities	762.97	802.48	621.03	456.57	124.82	86.97
Common Stock	420.78	420.78	420.78	420	420	420
Additional Paid-In Capital	887.92	883.62	888.35	886.2	873.78	873.78
Retained Earnings	-332.19	-324.06	-184.14	-108.07	16.12	66.26
Comprehensive Income & Other	1.51	0.55	0.55	0.85	-0.1	-0.19
Total Common Equity	978.03	980.89	1,126	1,199	1,310	1,360
Minority Interest	103.95	86.19	-	-	-	-
Shareholders' Equity	1,082	1,067	1,126	1,199	1,310	1,360
Total Liabilities & Equity	1,845	1,870	1,747	1,656	1,435	1,447
Total Debt	484.55	488.03	412.3	208.77	5.59	-
Net Cash (Debt)	-63.35	-46.5	28.8	277.78	600.43	781
Net Cash Growth	-	-	-89.63%	-53.74%	-23.12%	-
Net Cash Per Share	-0.18	-0.11	0.07	0.67	1.40	1.96
Filing Date Shares Outstanding	420.78	420.78	420.78	420	420	420
Total Common Shares Outstanding	420.78	420.78	420.78	420	420	420
Working Capital	263.87	245.87	380.81	470.78	734.39	933.72
Book Value Per Share	2.32	2.33	2.67	2.85	3.12	3.24
Tangible Book Value	646.53	633.81	997.71	1,068	1,168	1,292
Tangible Book Value Per Share	1.54	1.51	2.37	2.54	2.78	3.08
Buildings	-	393.46	375.44	344.92	217.76	217.76
Machinery	-	260.49	221.21	198.6	125.31	118.1
Construction In Progress	-	2.18	3.12	36.82	95.23	17.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.